Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements

Verfasser / Beitragende:
[R. B. Saraeva, I. D. Paskaleva, E. Doncheva, Chin-Bin Eap, V. S. Ganev]
Ort, Verlag, Jahr:
2007
Enthalten in:
Journal of Clinical Pharmacy and Therapeutics, 32/6(2007), 641-649
Format:
Artikel (online)
ID: 439455456